A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT)
2018 ◽
Vol 179
(4)
◽
pp. 836-843
◽
Keyword(s):
The Face
◽
2016 ◽
Vol 27
(6)
◽
pp. 525-530
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol Volume 10
◽
pp. 93-98
◽